Discover surprising truths about blindness, from the spectrum of visual impairment to revolutionary treatments and adaptive ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...